What this determination covers
The Department of Health, Disability and Ageing has registered the National Health (August 2026 First New Brand Statutory Price Reduction) (Exercise of Ministerial discretion) Determination 2026, dated 17 July 2026.
The determination records a Ministerial decision on statutory price reductions that apply when a first new brand of a listed medicine enters the Pharmaceutical Benefits Scheme (PBS) market, with effect in August 2026.
How PBS first new brand price reductions work
Under PBS pricing arrangements, a statutory price reduction mechanism applies when a new brand of an already-listed medicine is added to the PBS. The determination records the exercise of Ministerial discretion over how that price reduction is applied for the relevant August 2026 medicines.
What the source document does not specify
The registration metadata available for this instrument does not include:
- the specific medicines or brands affected
- the exact price reduction amounts
- medicine codes or schedule references
Key actions
- View the full determination at https://www.legislation.gov.au/F2026N00514 to identify which medicines are subject to the August 2026 price reduction.
- Check with your pharmacy software provider or PBS billing system to confirm updated PBS prices are loaded before August 2026 claims are submitted.
- Contact the Department of Health, Disability and Ageing if clarification is needed on which brands or medicine codes are affected.
This is a plain-English summary for information only, not legal or compliance advice. Always check the official source or consult a qualified professional.